Evaluation and implementation of new MRI techniques in the clinical routine of pediatric whole body imaging

Evaluation and implementation of new MRI techniques in the clinical routine of pediatric whole body imaging - fn_WB-MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00020462

Enrollment

Registered

2020-01-31

Start date

2020-05-29

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

various tumor diseases C00-C97 C81 C91 C40 C41

Interventions

Group 1: In children / adolescents from the age of 7 years who receive a wb-MRI from a clinical indication (in the case of CPS or follow-up of a tumor disease), additional MR sequences are integrated

Eligibility

Sex/Gender

All

Age

7 Years to 40 Years

Inclusion criteria

Inclusion criteria: Male and female patients >7 years - 40 years, transfer from pediatrics with a clinical indication for a (contrast-enhanced) MRI examination (Early detection or a follow-up check as standard of care of an oncological disease, all necessary laboratory parameters (creatinine / GFR according to UKT's internal guidelines) are available, no need for anesthesia for the examination, written consent to the study of the patient (depending on the level of development) and the legal guardian.

Exclusion criteria

Exclusion criteria: all MR-relevant exclusion criteria, all contrast medium-relevant exclusion criteria, the need for anesthesia for the examination, non-compliance of the patients for an MRI examination and a study-related extension of the examination time.

Design outcomes

Primary

Measure	Time frame
Qualitative and quantitative comparison between the newly implemented MR sequences compared to the MR standard protocol based on various criteria (resolution of certain anatomical structures and detection of benign and malignant lesions, exemplary focal bone lesions) for evaluating the image quality, sensitivity and specificity in the detection of malignant lesions.	—

Secondary

Measure	Time frame
Determination of movement artifacts occurring in new vs. MR sequences used as standard. Determination of the potential time saving by using new MR sequences.	—

Countries

Germany

Contacts

Public ContactJudith Herrmann

Universitätsklinikum Tübingen, Radiologische Klinik, Abt. für Diagnostische & Interventionelle Radiologie

judith.herrmann@med.uni-tuebingen.de07071-2968053

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026